Diagnoses and procedures of inpatients with female genital mutilation/cutting in Swiss University Hospitals: a cross-sectional study.
Coding
Female genital cutting
Female genital mutilation
Female genital mutilation/cutting
ICD
International classification of diseases
Switzerland
Journal
Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380
Informations de publication
Date de publication:
02 May 2022
02 May 2022
Historique:
received:
14
12
2021
accepted:
11
04
2022
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Female genital mutilation/cutting (FGM/C) can result in short and long-term complications, which can impact physical, psychological and sexual health. Our objective was to obtain descriptive data about the most frequent health conditions and procedures associated with FGM/C in Swiss university hospitals inpatient women and girls with a condition/diagnosis of FGM/C. Our research focused on the gynaecology and obstetrics departments. We conducted an exploratory descriptive study to identify the health outcomes of women and girls with a coded FGM/C diagnose who had been admitted to Swiss university hospitals between 2016 and 2018. Four of the five Swiss university hospitals provided anonymized data on primary and secondary diagnoses coded with the International Classification of Diseases (ICD) and interventions coded in their medical files. Between 2016 and 2018, 207 inpatients had a condition/diagnosis of FGM/C. The majority (96%) were admitted either to gynaecology or obstetrics divisions with few genito-urinary and psychosexual conditions coded. FGM/C coding capacities in Swiss university hospitals are low, and some complications of FGM/C are probably not diagnosed. Pregnancy and delivery represent key moments to identify and offer medical care to women and girls who live with FGM/C. This cross-sectional study (protocol number 2018-01851) was conducted in 2019, and approved by the Swiss ethics committee.
Sections du résumé
BACKGROUND
BACKGROUND
Female genital mutilation/cutting (FGM/C) can result in short and long-term complications, which can impact physical, psychological and sexual health. Our objective was to obtain descriptive data about the most frequent health conditions and procedures associated with FGM/C in Swiss university hospitals inpatient women and girls with a condition/diagnosis of FGM/C. Our research focused on the gynaecology and obstetrics departments.
METHODS
METHODS
We conducted an exploratory descriptive study to identify the health outcomes of women and girls with a coded FGM/C diagnose who had been admitted to Swiss university hospitals between 2016 and 2018. Four of the five Swiss university hospitals provided anonymized data on primary and secondary diagnoses coded with the International Classification of Diseases (ICD) and interventions coded in their medical files.
RESULTS
RESULTS
Between 2016 and 2018, 207 inpatients had a condition/diagnosis of FGM/C. The majority (96%) were admitted either to gynaecology or obstetrics divisions with few genito-urinary and psychosexual conditions coded.
CONCLUSIONS
CONCLUSIONS
FGM/C coding capacities in Swiss university hospitals are low, and some complications of FGM/C are probably not diagnosed. Pregnancy and delivery represent key moments to identify and offer medical care to women and girls who live with FGM/C.
TRIAL REGISTRATION
BACKGROUND
This cross-sectional study (protocol number 2018-01851) was conducted in 2019, and approved by the Swiss ethics committee.
Identifiants
pubmed: 35501902
doi: 10.1186/s12978-022-01411-z
pii: 10.1186/s12978-022-01411-z
pmc: PMC9063091
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104Informations de copyright
© 2022. The Author(s).
Références
BJOG. 2000 Dec;107(12):1507-12
pubmed: 11192108
BMC Public Health. 2021 May 29;21(1):1011
pubmed: 34051758
J Immigr Minor Health. 2020 Aug;22(4):668-674
pubmed: 31602532
BJOG. 2009 Aug;116(9):1204-9
pubmed: 19459862
BJOG. 2020 May;127(6):660-664
pubmed: 31930648
PLoS One. 2020 May 18;15(5):e0233440
pubmed: 32421757
Pediatrics. 2020 Aug;146(2):
pubmed: 32719089
J Womens Health (Larchmt). 2022 Mar;31(3):431-438
pubmed: 33926232
Bull World Health Organ. 2002;80(8):629-32
pubmed: 12219153
BMC Public Health. 2021 Jun 16;21(1):1151
pubmed: 34134688
Arch Dis Child. 2020 Nov;105(11):1075-1078
pubmed: 32499231
BMC Pregnancy Childbirth. 2016 Oct 28;16(1):328
pubmed: 27793119
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33380410
Reprod Health. 2021 Feb 12;18(1):39
pubmed: 33581732
BMJ Open. 2017 Aug 11;7(8):e017506
pubmed: 28801440
BMJ Open. 2014 Nov 21;4(11):e006316
pubmed: 25416059
Obstet Gynecol Int. 2014;2014:542859
pubmed: 25505915
PLoS Med. 2020 Mar 31;17(3):e1003088
pubmed: 32231359
Glob Public Health. 2019 Aug;14(8):1139-1152
pubmed: 30724649
Int J Gynaecol Obstet. 2016 Feb;132(2):174-8
pubmed: 26493013
Int Urogynecol J. 2018 Mar;29(3):339-344
pubmed: 28889193
Int J Gynaecol Obstet. 2017 Oct;139(1):21-27
pubmed: 28602042
BMJ. 2006 Jul 15;333(7559):124
pubmed: 16803943
PLoS One. 2020 Feb 26;15(2):e0229815
pubmed: 32101586
Int J Gynaecol Obstet. 2014 Jun;125(3):256-60
pubmed: 24713414
Best Pract Res Clin Obstet Gynaecol. 2016 Apr;32:88-99
pubmed: 26458998
BMC Int Health Hum Rights. 2015 Dec 10;15:32
pubmed: 26652275
Arch Dis Child. 2021 Apr;106(4):372-376
pubmed: 33023890
Am J Public Health. 2020 Jan;110(1):112-118
pubmed: 31725330
Lancet. 2006 Jun 3;367(9525):1835-41
pubmed: 16753486
Eur J Contracept Reprod Health Care. 2016 Dec;21(6):474-482
pubmed: 27652839
Child Abuse Negl. 2016 May;55:1-9
pubmed: 27045807
J Travel Med. 2018 Jan 1;25(1):
pubmed: 29394392
Reprod Health. 2017 Aug 8;14(1):92
pubmed: 28789667
Reprod Health. 2020 Jul 8;17(1):105
pubmed: 32641062
Birth. 2019 Mar;46(1):15-23
pubmed: 30294872
Eur J Popul. 2017 May 16;33(4):559-583
pubmed: 30976237
SSM Popul Health. 2017 Dec;3:283-293
pubmed: 29302613
BMC Health Serv Res. 2018 Jul 24;18(1):579
pubmed: 30041654